SCHEMBL25317454

SCHEMBL25317454

C1=CCC2CCC(c3ccccc3)C2=C1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C1 Q04828 1/20 0.33
DDB1 Q16531 1/20 0.32
CRBN Q96SW2 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
ALOX12 P18054 1/20 0.31
MAPK1 P28482 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TP53 P04637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
GRIN2B Q13224 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10317513 0.82 SLC6A4 (0.43) KDM4E
SCHEMBL4332382 0.76 DDB1 (0.39) DDB1CRBNKDM4EALDH1A1MAPT
Hydrochloric Acid SCHEMBL6470006 0.76
SCHEMBL8427103 0.73
SCHEMBL28639482 0.72
Hydrochloric Acid SCHEMBL6469568 0.71
SCHEMBL28378608 0.71 TSHR (0.37) SLC18A3SIGMAR1AKR1C3AKR1C1KDM4E
SCHEMBL12818013 0.71 SLC6A2 (0.36) DDB1CRBN
SCHEMBL10320042 0.71
SCHEMBL12815045 0.71 CYP3A4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103484-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME SABIC SK NEXLENE COMPANY PTE LTD (SG) 2026-04-16 US disclosed
US-20250171572-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2025-05-29 US disclosed
EP-4457233-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME SABIC SK Nexlene Company Pte. Ltd. (SG) 2024-11-06 EP disclosed
CN-118475588-A Transition metal compound, catalyst composition comprising the same, and method for preparing olefin polymer using the same 沙特基础工业爱思开NEXLENE私人有限公司 2024-08-09 CN disclosed
CN-114746432-B Transition metal compound, catalyst composition comprising the same, and process for producing olefin polymer using the catalyst composition 沙特基础工业爱思开NEXLENE私人有限公司 2024-06-21 CN disclosed
WO-2024074937-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION CONTAINING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2024-04-11 WO disclosed
WO-2024069256-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2024-04-04 WO disclosed
WO-2023126845-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME SABIC SK NEXLENE COMPANY PTE. LTD. (SG) 2023-07-06 WO disclosed
CN-114746432-A Transition metal compound, catalyst composition comprising the same, and process for producing olefin polymer using the catalyst composition 沙特基础工业爱思开NEXLENE私人有限公司 2022-07-12 CN disclosed
CN-102046670-B Ethylene-propylene-diene copolymer production method SK ENERGY CO LTD 2014-08-27 CN disclosed
CN-102046670-A Ethylene-propylene-diene copolymer production method SK ENERGY CO LTD 2011-05-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103484-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME MMP20, CYC1, SOD1 SLC18A3 2741/4885SIGMAR1 2942/4885AKR1C3 618/4885
US-20250171572-A1 TRANSITION METAL COMPOUND, CATALYST COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING OLEFIN POLYMER USING THE SAME NOTUM, OSTC, ODC1 SLC18A3 2941/4885SIGMAR1 4456/4885AKR1C3 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.